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The interaction of ERα and ERβ with ERE constitutes the initial step in the canonical nuclear E2 signaling in
which E2-ERβ is a weaker transactivator than E2-ERα.This perspective summarizes recent findings to discuss
potential mechanisms that contribute to ER subtype-specific transcriptional responses.
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Estrogen receptors and estrogen
signaling
Estradiol information is primarily conveyed by the
members of a nuclear receptor superfamily, estrogen
receptor (ER) α and β [Hall et al., 2001]. ERs are encoded
by two distinct genes and expressed in the same and
different tissues at varying levels. ERs consist of six
functional domains.The structurally distinct amino
terminal A/B domains (17% amino-acid identity) contain
a ligand-independent transactivation function (AF1).The
near identical central C region is the DNA binding domain
(DBD).The flexible hinge, or D, domain contains a nuclear
localization signal and links the C domain to the
multi-functional carboxyl terminal (E/F) domain. E/F, which
shows 56% amino-acid homology between ERs, is
involved in ligand binding, dimerization, and
ligand-dependent transactivation function (AF2).
ApoERs dimerize and translocate to the nucleus, likely
as a part of large protein complexes [Zheng et al., 2005],
independent of E2 [Bai and Giguere, 2003; Huang et al.,
2005].The nuclear apoERs are highly mobile molecules
dynamically partitioned between intracellular target sites
on chromatin and nuclear matrix [Stenoien et al., 2001].
ApoERs associate with ERE [Chen et al., 1999; Huang
et al., 2005], permutations of a palindromic DNA
sequence with three central non-specific nucleotides,
5’-GGTCAnnnTGACC-3' [Klinge, 2001].
ERα-mediated signaling
Elegant kinetic studies using the pS2 promoter as a model
indicate that the engagement of apoERα with ERE occurs
cyclically with short periods requiring both activating and
repressing epigenetic processes [Metivier et al., 2004;
Metivier et al., 2003; Reid et al., 2003]. ApoERα through
the amino- and carboxyl-termini interacts [Webb et al.,
1998;Yi et al., 2002b], albeit inefficiently, with highly
mobile heterogeneous coregulator complexes [Stenoien
et al., 2001] including protein and chromatin modifiers.
Further protein alterations, including ubiquitination, of
apoERα and associated coregulators, disassembles the
transcription complex for proteasomal degradation
[Lonard et al., 2000;Wang et al., 2001].This is followed
by promoter remodeling through the association of
modifiers with basal transcription factors [Metivier et al.,
2004; Metivier et al., 2003; Reid et al., 2003].This
oscillating promoter restructuring is suggested to provide
a mechanism that enables a rapid adaptation of
transcription to E2 [Metivier et al., 2004].
The binding of E2 to apoERα is accompanied by a
conformational shift in the carboxyl-terminus that
enhances the stability of the ERα dimer [Bai and Giguere,
2003], and generates a binding surface for stable
interaction with cofactors [Hall et al., 2001]. E2 also
increases the association of ERα with ERE [Chen et al.,
1999; Huang et al., 2005]. Although mechanism is
unclear, pre- and post-ERE binding events likely
participate in the E2-mediated augmentation of ERα-ERE
interactions. One possible pre-ERE binding event involves
allosteric alteration of the folding or the stability of the
DBD of ERα upon binding to E2 that lead to an increase
in the population of the receptor capable of interacting
with ERE. Alternatively, E2 mediates the dissociation of
ERα from chaperones/nuclear matrix-associated proteins
bound to the DBD, or to other regions that sterically block
the DBD [Oesterreich, 2003; Pratt et al., 1996].This could
unmask DBD that allows ERα-ERE interactions.
Additionally, E2 could influence the intermolecular
association of ERα with protein complexes to enhance
the stability of ERα-ERE interactions [Loven et al., 2003;
Petz et al., 2002]. Pre-ERE binding events may also affect
the partitioning of E2-ERα to chromatin from nuclear
matrix, reflected as a decrease in the mobility of E2-ERα
[Stenoien et al., 2001].
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a series of interdependent events that result in an
extended periodicity of cyclic engagement [Metivier et
al., 2004; Metivier et al., 2003; Reid et al., 2003].This
raises the possibility that post-ERE binding events also
contribute to the E2-mediated increase in ERα-ERE
interaction. In addition to the ability of the amino-terminus
ERα to interact with coregulators independent of E2, the
binding of E2 dramatically enhances the affinity of AF2
for coregulators [Yi et al., 2002b]. An effective recruitment
of coregulators by both AF1 and AF2 could form a stable
platform necessary for subsequent combinatorial
recruitment of distinct mediators, integrators, and
ubiquitin-proteasome pathway enzymes. Integrated
actions of these complexes could extensively remodel
chromatin leading to an increase in the duration of
promoter occupancy of E2-ERα.
However, the formation of a stable and transcriptionally
productive complex may not be sufficient to explain the
E2-mediated increase in ERα-ERE interaction.
Transcriptionally impaired ER variants with abrogated
AF1 and/or AF2 display an E2-mediated increase in ERE
binding and cyclical promoter occupancy that are
indistinguishable from those observed with ERα [Huang
et al., 2005; Metivier et al., 2004;Valley et al., 2005].
Since variant ERs undergo distinct proteasome-mediated
degradations [Valley et al., 2005], a delay in the
disassembly of the transcription complex could also
extend the duration of E2-ERα promoter occupancy.
Post-translational modifications, including
phosphorylation, acetylation, sumoylation and/or
ubiquitination, could influence the periodicity of the
promoter occupancy of ERα by providing unique target
surfaces for the recruitment of distinct coregulators that
differentially modify the amplitude of transcription.
Modifications could also affect the degradation of ERα
independently from transcription. Although ApoERα and
E2-ERα are degraded through the ubiquitin-proteasome
pathway, E2 dramatically enhances the ubiquitination of
ERα [Valley et al., 2005;Wijayaratne and McDonnell,
2001]. It is possible that a delay in the sequence of events
leading to poly-ubiquitination could prolong the
association of E2-ERα with the promoter. Lysine residues,
for example, serve as common attachment sites for
acetylation and sumoylation of the hinge domain of ERα,
the latter of which is strictly dependent upon E2 binding
[Sentis et al., 2005;Wang et al., 2001]. Since
post-translational processing is a reversible and dynamic
process, sumoylation or acetylation, prior to
poly-ubiquitination, could modify ERα activity.These
modifications could also disguise the recognition of the
receptor as a proteolytic substrate for degradation,
extending the promoter occupancy. Similarly,
phosphorylation status of ERα could increase the duration
of promoter engagement by uncoupling transactivation
from degradation through the repression of
poly-ubiquitination and subsequent ERα turnover [Valley
et al., 2005].
We suggest that the E2-mediated increase in ERα-ERE
interaction involves both pre- and post-ERE binding
events that are manifested as increases in the population
of ERα capable of interacting with ERE and in the
periodicity of cyclic engagement of ERα with estrogen
responsive promoters.
ERβ-mediated signaling
Although ERs show similar DNA and ligand binding
properties in vitro, ERβ is less effective than ERα in
inducing transcription from the ERE-dependent signaling
pathway [McInerney et al., 1998;Yi et al., 2002a]. Despite
a plethora of studies, comparatively little is known about
mechanisms of ERβ action. It appears that AF1 is critical
for defining the receptor-subtype specific activity.The
amino-terminus of ERβ, in contrast to ERα, lacks
significant transcriptional capacity and capability of
functional interaction with the carboxyl-terminus
[McInerney et al., 1998;Yi et al., 2002a]. Our recent study
indicated that in contrast to ERα, the interaction of ERβ
with ERE is independent of E2 and is impaired by its
amino-terminus, contributing to transfection inefficiency
of the receptor [Huang et al., 2005]. Although how the
amino-terminus affects the binding of ERβ to ERE is not
clear, the inter- and/or intramolecular interactions of the
ERβ amino-terminus could sterically mask or allosterically
affect the folding of the DBD.This could limit the
population of ERβ capable of interacting with ERE.That
truncation of the amino-terminus of ERβ dramatically
enhanced the variant ERβ-ERE interaction compared to
that observed with ERβ lends credence to this conclusion.
However, the binding of the truncated ERβ to ERE
remained independent of E2 unless AF2 was also
obliterated.This implies that the binding of a factor(s) to
the carboxyl-terminus induces a conformation in ERβ that
resembles that mediated by the E2 binding.This
contrasted to the amino-terminally truncated ERα with or
without AF2 that showed an E2-mediated increase in
ERE binding similar to ERα.Thus, although the
amino-terminus of ERβ is a dominant region to impair
ERβ-ERE interaction, the structural basis for the
differential effect of E2 on ER-ERE interactions resides
in the carboxyl-termini of ERs.
Studies indicate that ERα interacts, albeit weakly, with
SMRT and NCoR, in the absence of E2 [Lavinsky et al.,
1998;Webb et al., 2003].The binding of E2 to ERα
releases co-repressors from ERα. Apo-ERβ also interacts
with SMRT/NCoR through a region that encompasses
AF2 [Webb et al., 2003]. However, E2 does not promote
the dissociation of corepressors from ERβ [Webb et al.,
2003]. If indeed the conformation of the ERβ
carboxyl-terminus bound to corepressors mimicked the
conformation mediated by E2, the E2 effect on ERβ-ERE
interaction would then be masked.This could explain why
the interaction of ERβ with ERE appears to be
independent of E2. Since, however, E2 is necessary for
transactivation, E2 must also convert the inactive
ERE-bound ERβ to a transcriptionally active state by
concurrently recruiting coactivators through a distinct
cofactor interacting surface(s).The presence of both
coactivators and corepressors could be responsible for
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Although it is likely that ERβ engages with responsive
promoters cyclically, the duration of promoter engagement
may be similar for both apo- and E2-ERβ, as opposed to
ERα, for which E2 is critical for determining the duration
of promoter occupancy.The mode of promoter
engagement of ERβ, however, could be modified by
heterodimerization with ERα when co-expressed [Li et
al., 2004] and by post-translational modifications
[Tremblay et al., 1999] that likely alter pre- or post-ERE
binding of ERβ.
Future studies directed to a better understanding of the
mechanism of ER subtype-specific transcriptional
responses will clarify these issues, and could provide a
basis for the development of novel therapeutic
approaches for estrogen target tissue malignancies.
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